BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 25385028)

  • 1. LASP1 is a HIF1α target gene critical for metastasis of pancreatic cancer.
    Zhao T; Ren H; Li J; Chen J; Zhang H; Xin W; Sun Y; Sun L; Yang Y; Sun J; Wang X; Gao S; Huang C; Zhang H; Yang S; Hao J
    Cancer Res; 2015 Jan; 75(1):111-9. PubMed ID: 25385028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular lumican inhibits pancreatic cancer cell growth and is associated with prolonged survival after surgery.
    Li X; Truty MA; Kang Y; Chopin-Laly X; Zhang R; Roife D; Chatterjee D; Lin E; Thomas RM; Wang H; Katz MH; Fleming JB
    Clin Cancer Res; 2014 Dec; 20(24):6529-40. PubMed ID: 25336691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EGFR-induced phosphorylation of type Iγ phosphatidylinositol phosphate kinase promotes pancreatic cancer progression.
    Chen C; Wang X; Fang J; Xue J; Xiong X; Huang Y; Hu J; Ling K
    Oncotarget; 2017 Jun; 8(26):42621-42637. PubMed ID: 28388589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia-inducible factor-1α regulates chemotactic migration of pancreatic ductal adenocarcinoma cells through directly transactivating the CX3CR1 gene.
    Zhao T; Gao S; Wang X; Liu J; Duan Y; Yuan Z; Sheng J; Li S; Wang F; Yu M; Ren H; Hao J
    PLoS One; 2012; 7(8):e43399. PubMed ID: 22952674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Focal adhesion protein Lasp1 links the Arp2/3 complex to adherens junctions and promotes motility of arthritic fibroblast-like synoviocytes.
    Beckmann D; Krause A; Hansen U; Kiener HP; Karonitsch T; Blüml S; Kremerskothen J; Pavenstädt H; Pap T; Korb-Pap A
    Ann Rheum Dis; 2024 May; 83(6):816-819. PubMed ID: 38373844
    [No Abstract]   [Full Text] [Related]  

  • 6. CD73 controls Myosin II-driven invasion, metastasis, and immunosuppression in amoeboid pancreatic cancer cells.
    Samain R; Maiques O; Monger J; Lam H; Candido J; George S; Ferrari N; KohIhammer L; Lunetto S; Varela A; Orgaz JL; Vilardell F; Olsina JJ; Matias-Guiu X; Sarker D; Biddle A; Balkwill FR; Eyles J; Wilkinson RW; Kocher HM; Calvo F; Wells CM; Sanz-Moreno V
    Sci Adv; 2023 Oct; 9(42):eadi0244. PubMed ID: 37851808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MYB sustains hypoxic survival of pancreatic cancer cells by facilitating metabolic reprogramming.
    Anand S; Khan MA; Zubair H; Sudan SK; Vikramdeo KS; Deshmukh SK; Azim S; Srivastava SK; Singh S; Singh AP
    EMBO Rep; 2023 Mar; 24(3):e55643. PubMed ID: 36592158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STIM1- and Orai1-mediated Ca(2+) oscillation orchestrates invadopodium formation and melanoma invasion.
    Sun J; Lu F; He H; Shen J; Messina J; Mathew R; Wang D; Sarnaik AA; Chang WC; Kim M; Cheng H; Yang S
    J Cell Biol; 2014 Nov; 207(4):535-48. PubMed ID: 25404747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival among patients with pancreatic cancer and long-standing or recent-onset diabetes mellitus.
    Yuan C; Rubinson DA; Qian ZR; Wu C; Kraft P; Bao Y; Ogino S; Ng K; Clancy TE; Swanson RS; Gorman MJ; Brais LK; Li T; Stampfer MJ; Hu FB; Giovannucci EL; Kulke MH; Fuchs CS; Wolpin BM
    J Clin Oncol; 2015 Jan; 33(1):29-35. PubMed ID: 25403204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia-inducible factors are required for chemotherapy resistance of breast cancer stem cells.
    Samanta D; Gilkes DM; Chaturvedi P; Xiang L; Semenza GL
    Proc Natl Acad Sci U S A; 2014 Dec; 111(50):E5429-38. PubMed ID: 25453096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological inhibition and genetic knockdown of exchange protein directly activated by cAMP 1 reduce pancreatic cancer metastasis in vivo.
    Almahariq M; Chao C; Mei FC; Hellmich MR; Patrikeev I; Motamedi M; Cheng X
    Mol Pharmacol; 2015 Feb; 87(2):142-9. PubMed ID: 25385424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Podoplanin promotes the invasion of oral squamous cell carcinoma in coordination with MT1-MMP and Rho GTPases.
    Li YY; Zhou CX; Gao Y
    Am J Cancer Res; 2015; 5(2):514-29. PubMed ID: 25973294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An update on the LIM and SH3 domain protein 1 (LASP1): a versatile structural, signaling, and biomarker protein.
    Orth MF; Cazes A; Butt E; Grunewald TG
    Oncotarget; 2015 Jan; 6(1):26-42. PubMed ID: 25622104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. STAT3 induces anoikis resistance, promotes cell invasion and metastatic potential in pancreatic cancer cells.
    Fofaria NM; Srivastava SK
    Carcinogenesis; 2015 Jan; 36(1):142-50. PubMed ID: 25411359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ITGBL1 Is a Runx2 Transcriptional Target and Promotes Breast Cancer Bone Metastasis by Activating the TGFβ Signaling Pathway.
    Li XQ; Du X; Li DM; Kong PZ; Sun Y; Liu PF; Wang QS; Feng YM
    Cancer Res; 2015 Aug; 75(16):3302-13. PubMed ID: 26060017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Pancreatic Cancer Metastasis by Inhibition of Vav1, a Driver of Tumor Cell Invasion.
    Razidlo GL; Magnine C; Sletten AC; Hurley RM; Almada LL; Fernandez-Zapico ME; Ji B; McNiven MA
    Cancer Res; 2015 Jul; 75(14):2907-15. PubMed ID: 25977335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulating HIF-1α by lentivirus-mediated shRNA for therapy of triple negative breast cancer.
    Li S; Wei Q; Li Q; Zhang B; Xiao Q
    Cancer Biol Ther; 2015; 16(6):866-75. PubMed ID: 25920936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-33a functions as a tumor suppressor in melanoma by targeting HIF-1α.
    Zhou J; Xu D; Xie H; Tang J; Liu R; Li J; Wang S; Chen X; Su J; Zhou X; Xia K; He Q; Chen J; Xiong W; Cao P; Cao K
    Cancer Biol Ther; 2015; 16(6):846-55. PubMed ID: 25891797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Full-Length Semaphorin-3C Is an Inhibitor of Tumor Lymphangiogenesis and Metastasis.
    Mumblat Y; Kessler O; Ilan N; Neufeld G
    Cancer Res; 2015 Jun; 75(11):2177-86. PubMed ID: 25808871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-delivery of HIF1α siRNA and gemcitabine via biocompatible lipid-polymer hybrid nanoparticles for effective treatment of pancreatic cancer.
    Zhao X; Li F; Li Y; Wang H; Ren H; Chen J; Nie G; Hao J
    Biomaterials; 2015 Apr; 46():13-25. PubMed ID: 25678112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.